Search results
Finding the Best Psoriasis Treatment: How I Got Psoriasis Relief
Verywell Health via Yahoo News· 7 hours agoMy arms were cherry red due to...in 2010, but knowing I wanted more babies deterred me from seeking ...
Nail Psoriasis
Health via Yahoo News· 5 days agoPeople with moderate to severe forms of both conditions may live a few years less on average. Early diagnosis, treatment, and management of your...
J&J’s Tremfya meets endpoints in Phase III ulcerative colitis trial
Clinical Trials Arena via Yahoo Finance· 14 hours agoJ&J’s Tremfya is expected to be the successor to the company’s IL-12/IL-23 inhibitor Stelara...
BMS reports four-year data from psoriasis treatment extension trial
Clinical Trials Arena via Yahoo Finance· 5 days agoThe study followed the Phase III POETYK PSO-1 and POETYK PSO-2...remained consistent over the four...
InnoCare Pharma concludes subject enrolment Phase II psoriasis trial
Clinical Trials Arena via Yahoo Finance· 6 days agoInnoCare Pharma has announced the completion of subject enrolment in the Phase II clinical trial of...
Teva and Alvotech Announce SIMLANDI® (adalimumab-ryvk) Injection Now Available in the U.S. -...
Benzinga· 1 day agoALVO, today announced the availability of SIMLANDI (adalimumab-ryvk) injection in the U.S., as an interchangeable biosimilar to Humira for the treatment of adult rheumatoid ...
TREMFYA® (guselkumab) QUASAR Maintenance Study in UC met its primary endpoint and all major...
FOX 23 News Albany· 2 days ago...20, 2024 /PRNewswire/ -- Johnson & Johnson today announced the first data from the Phase 3 QUASAR Maintenance Study (Abstract #759) that showed 50.0 percent (p<0.001) of patients with moderately to severely active ulcerative colitisa (UC) receiving subcutaneous (SC) TREMFYA® (guselkumab) 200 mg...
State board targets six prescription drugs to review for affordability for Marylanders
Maryland Matters via Yahoo News· 1 day agoThe board will seek public comments, additional information and data over the next 60 days to...
Ultravate side effects: What they are and how to manage them
Healthline· 2 days agoUltravate (halobetasol propionate) is a prescription drug that’s used to treat plaque psoriasis. Ultravate can cause side effects that range from mild to ...
AbbVie Presents New Data Supporting Leading Gastroenterology Portfolio at 2024 Digestive Disease...
WFRV 5 Green Bay· 5 days ago...from the SEQUENCE head-to-head trial comparing risankizumab (SKYRIZI®) versus ustekinumab (STELARA®) in Crohn's disease include an economic analysis and oral presentation that assessed inflammation biomarkers - Additional presentations include efficacy and safety data evaluating clinical,...